BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 33672103)

  • 1. The Potential of Hydrogen Sulfide Donors in Treating Cardiovascular Diseases.
    Wang YZ; Ngowi EE; Wang D; Qi HW; Jing MR; Zhang YX; Cai CB; He QL; Khattak S; Khan NH; Jiang QY; Ji XY; Wu DD
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of Hydrogen Sulfide Therapeutics to Treat Cardiovascular Disease.
    Li Z; Polhemus DJ; Lefer DJ
    Circ Res; 2018 Aug; 123(5):590-600. PubMed ID: 30355137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease.
    Polhemus DJ; Lefer DJ
    Circ Res; 2014 Feb; 114(4):730-7. PubMed ID: 24526678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Actions of H2S in Acute Myocardial Infarction and Heart Failure.
    Donnarumma E; Trivedi RK; Lefer DJ
    Compr Physiol; 2017 Mar; 7(2):583-602. PubMed ID: 28333381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Development of Hydrogen Sulfide Therapeutics in the Treatment of Cardiovascular Diseases.
    Peng W; Guo W; Zheng Y
    Curr Top Med Chem; 2021; 21(24):2230-2242. PubMed ID: 34488613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel H
    Testai L; Marino A; Piano I; Brancaleone V; Tomita K; Di Cesare Mannelli L; Martelli A; Citi V; Breschi MC; Levi R; Gargini C; Bucci M; Cirino G; Ghelardini C; Calderone V
    Pharmacol Res; 2016 Nov; 113(Pt A):290-299. PubMed ID: 27616550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular Diseases.
    Luo W; Gui DD; Yan BJ; Ren Z; Peng LJ; Wei DH; Liu LS; Zhang DW; Jiang ZS
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):113-121. PubMed ID: 32090295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen sulfide rescues high glucose-induced migration dysfunction in HUVECs by upregulating miR-126-3p.
    Xue WL; Chen RQ; Zhang QQ; Li XH; Cao L; Li MY; Li Y; Lin G; Chen Y; Wang MJ; Zhu YC
    Am J Physiol Cell Physiol; 2020 May; 318(5):C857-C869. PubMed ID: 32186933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen sulfide and its donors: Novel antitumor and antimetastatic agents for liver cancer.
    Zhang CH; Jiang ZL; Meng Y; Yang WY; Zhang XY; Zhang YX; Khattak S; Ji XY; Wu DD
    Cell Signal; 2023 Jun; 106():110628. PubMed ID: 36774973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen sulfide and its donors for the treatment of cerebral ischaemia-reperfusion injury: A comprehensive review.
    Huang Y; Omorou M; Gao M; Mu C; Xu W; Xu H
    Biomed Pharmacother; 2023 May; 161():114506. PubMed ID: 36906977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium Sulfide Attenuates Ischemic-Induced Heart Failure by Enhancing Proteasomal Function in an Nrf2-Dependent Manner.
    Shimizu Y; Nicholson CK; Lambert JP; Barr LA; Kuek N; Herszenhaut D; Tan L; Murohara T; Hansen JM; Husain A; Naqvi N; Calvert JW
    Circ Heart Fail; 2016 Apr; 9(4):e002368. PubMed ID: 27056879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen sulfide as a potent cardiovascular protective agent.
    Yu XH; Cui LB; Wu K; Zheng XL; Cayabyab FS; Chen ZW; Tang CK
    Clin Chim Acta; 2014 Nov; 437():78-87. PubMed ID: 25058799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen Sulfide in Physiological and Pathological Mechanisms in Brain.
    Kumar M; Sandhir R
    CNS Neurol Disord Drug Targets; 2018; 17(9):654-670. PubMed ID: 29866024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen sulfide and autophagy: A double edged sword.
    Wu D; Wang H; Teng T; Duan S; Ji A; Li Y
    Pharmacol Res; 2018 May; 131():120-127. PubMed ID: 29514056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of hydrogen sulfide-microRNA crosstalk in cardiovascular diseases.
    Hackfort BT; Mishra PK
    Am J Physiol Heart Circ Physiol; 2016 Apr; 310(7):H802-12. PubMed ID: 26801305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis.
    Zhang S; Pan C; Zhou F; Yuan Z; Wang H; Cui W; Zhang G
    Oxid Med Cell Longev; 2015; 2015():593407. PubMed ID: 26078809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen Sulfide in Pharmacotherapy, Beyond the Hydrogen Sulfide-Donors.
    Zaorska E; Tomasova L; Koszelewski D; Ostaszewski R; Ufnal M
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32085474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Patents on Therapeutic Potential and Delivery of Hydroge n Sulfide.
    Verma R; Akhtar Y; Singh S
    Recent Pat Drug Deliv Formul; 2017; 11(2):114-123. PubMed ID: 28901845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H
    Jia J; Li J; Cheng J
    Stroke Vasc Neurol; 2019 Jul; 4(2):63-66. PubMed ID: 31338211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen sulfide (H2S) releasing agents: chemistry and biological applications.
    Zhao Y; Biggs TD; Xian M
    Chem Commun (Camb); 2014 Oct; 50(80):11788-805. PubMed ID: 25019301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.